["{\"step_by_step_thinking\": \"The question is about the effectiveness of glucagon injection for management of persistent hypoglycemia. The relevant documents describe various causes of neonatal hypoglycemia, including insulin excess and islet cell dysplasia. 95% pancreatectomy is recommended as the initial procedure in the treatment of persistent idiopathic neonatal hypoglycemia due to islet cell dysplasia. Glucagon does not contribute significantly to the mechanism for enhanced plasma cAMP release during insulin-induced hypoglycemia, which is catecholamine dependent. Injection therapy has its own specific application in varicose veins, and diarrhea training and treatment units (DTUs) are established to improve case management of diarrhea.\", \"answer_choice\": D}"]